| Line Item | 2023-10-31 | Y/Y |
|---|---|---|
| Revenue | $5.46B | +0.8% |
| Cost of Revenue | $1.93B | -1.9% |
| R&D Expense | $882.0M | +4.9% |
| SG&A Expense | $1.31B | +1.9% |
| Operating Income | $1.36B | +1.8% |
| Interest Expense | $78.0M | -1.3% |
| Pre-tax Income | $1.36B | +5.6% |
| Income Tax | $300.0M | +86.3% |
| Net Income | $1.06B |
| Line Item | 2023-10-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.47B | +21.1% |
| Accounts Receivable | $900.0M | -0.6% |
| Inventory | $985.0M | +14.8% |
| Current Assets | $4.81B | +13.6% |
| Total Assets | $8.68B | +7.2% |
| Current Liabilities | $2.05B | +45.6% |
| Long-term Debt | $1.79B | +0.1% |
| Line Item | 2023-10-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.41B | +23.1% |
| Capital Expenditures | $196.0M | +5.9% |
| Investing Cash Flow | -$288.0M | -14.7% |
| Financing Cash Flow | -$687.0M | +20.2% |
| Free Cash Flow | $1.21B | +26.4% |
| -6.0% |
| EPS (Basic) | $5.95 | -4.5% |
| EPS (Diluted) | $5.91 | -4.4% |
| Total Liabilities |
| $4.03B |
| +2.3% |
| Stockholders' Equity | $4.65B | +11.8% |